Exir Pharmaceutical Co.
TaiwanFDA 510(k) applicant, unverified
- Devices
- 1
What Exir Pharmaceutical Co. makes
Exir Pharmaceutical Co. manufactures the MAXIMED EXICHEK TD-4224, a blood glucose monitoring system designed for measuring glucose levels in blood samples.
The company’s portfolio is regulated under FDA Class II devices and includes submissions via the 510(k) pathway. The manufacturer is based in the United States.
Catalogue
- 510(k) 510(k)
Frequently asked questions
How many devices does Exir Pharmaceutical Co. have in the registry?
The registry currently lists 1 device for Exir Pharmaceutical Co.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Exir Pharmaceutical Co.'s devices?
Among its 1 most recently registered device, Exir Pharmaceutical Co. has devices listed in FDA 510(k) (1 device).
What risk classes do Exir Pharmaceutical Co.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Exir Pharmaceutical Co.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Exir Pharmaceutical Co. in the registry?
The most recently registered devices listed for Exir Pharmaceutical Co. include MAXIMED EXICHEK TD-4224 BLOOD GLUCOSE MONITORING SYSTEM.